# Therapeutic/Mechanistic Hypotheses: Subcellular Compartmentalization Biomarkers in Living Neurons
---
## Hypothesis 1: Mitochondrial Compartment-Specific Proteostasis Reporter System
**Title:** A genetically encoded reporter for axonal mitochondrial protein import fidelity as a biomarker of compartmentalization
**Mechanism:** Defects in mitochondrial protein import (via TOM40/TOM20 translocase) represent an early and measurable compartmentalization failure. A fusion construct consisting of GFP with a mitochondrial targeting sequence (MTS) that requires proper import machinery will serve as a direct read-out of compartmentalized proteostasis capacity.
**Target Gene/Protein/Pathway:**
- TOM20/TOM40 translocase complex
- Mitochondrial matrix-localized GFP with destabilization domain (dGFP) for rapid turnover
- Stress-responsive CHOP promoter driving alternative fluorescent protein
**Supporting Evidence:**
- Mitochondrial import defects documented in ALS models (PMID: 30209046)
- Axonal mitochondrial dysfunction precedes neurodegeneration in AD (PMID: 27545678)
- TOMM20 level alterations serve as biomarker in patient-derived neurons (PMID: 31196453)
**Predicted Experiment:** Lentiviral transduction of iPSC-derived neurons with MTS-dGFP reporter; longitudinal ratiometric imaging of mitochondrial import efficiency; correlative cryo-EM of import pore morphology in same cells.
**Confidence:** 0.68
---
## Hypothesis 2: Synaptic-Primary Cilium Shared Signaling Axis as Dual Compartment Reporter
**Title:** Sonic hedgehog pathway compartmentalization as quantitative biomarker for neuronal polarity defects
**Mechanism:** Primary cilium and synaptic compartments share signaling machinery including GPCRs and adenylate cyclase. Disruption of compartmentalized cAMP signaling in one compartment while preserving it in another constitutes a measurable and targetable compartmentalization defect. FRET-based cAMP sensors targeted to each compartment will provide ratiometric read-out.
**Target Gene/Protein/Pathway:**
- Adenylate cyclase 3 (ADCY3), Gαs, cAMP
- ARL13B (ciliary), PSD95 (postsynaptic)
- FRET sensor Epac1-camps targeted to each compartment
**Supporting Evidence:**
- Ciliary signaling defects in Huntington's disease (PMID: 31138801)
- Ciliopathy phenotypes in iPSC neurons with neurodevelopmental disorders (PMID: 29712963)
- Synaptic polarity establishment requires compartmentalized cAMP (PMID: 28335004)
**Predicted Experiment:** Divide-neurons assay with ciliary vs. synaptic FRET sensors; pharmacological challenge with SMO agonist to test compartmentalization reserve capacity; validation in patient-derived neurons.
**Confidence:** 0.55
---
## Hypothesis 3: Liquid-Liquid Phase Separation Resilience as Compartmentalization Metric
**Title:** TDP-43 condensation thermodynamics as a therapeutic target and biomarker for nuclear-cytoplasmic compartmentalization
**Mechanism:** Pathological TDP-43 forms irreversible aggregates in cytoplasm, but the transition from reversible liquid droplets (physiological) to solid aggregates (pathological) may represent a quantifiable compartmentalization failure. Fluorescence recovery after photobleaching (FRAP) kinetics of TDP-43 in living neurons provide a continuous metric of phase separation state that predicts therapeutic response.
**Target Gene/Protein/Pathway:**
- TDP-43 (TARDBP gene product)
- Nuclear import receptor IPO4/IP09
- Stress granule dynamics via G3BP1 co-phase separation
**Supporting Evidence:**
- TDP-43 pathology in >95% of ALS cases (PMID: 19042910)
- Nuclear import defects cause cytoplasmic TDP-43 accumulation (PMID: 30540933)
- Phase separation of TDP-43 directly observed by super-resolution (PMID: 31439799)
**Predicted Experiment:** CRISPR knock-in of endogenously-tagged TDP-43-eGFP in iPSC neurons; FRAP in axonal vs. somatic compartments; correlation with nuclear pore complex integrity measured by mAb414 immunostaining.
**Confidence:** 0.75
---
## Hypothesis 4: Axonal Endosomal EGFR-Like Signaling Compartment as Therapeutic Target
**Title:** Retromer-dependent retrograde endosomal signaling compartmentalization as biomarker and intervention point
**Mechanism:** The retromer complex (VPS26/VPS29/VPS35) maintains axonal endosomal signaling microdomains. Impaired retromer function causes mislocalization of neurotrophin receptors (TrkB, p75NTR) to somatodendritic compartments, disrupting synaptic plasticity. Measurement of TrkB endosomal trafficking kinetics provides biomarker; retromer enhancement provides therapy.
**Target Gene/Protein/Pathway:**
- Retromer complex (VPS35 P294S variant increases AD risk, PMID: 23314016)
- TrkB receptor axonal trafficking
- Rab7/Rab11 in endosomal maturation
**Supporting Evidence:**
- VPS35 mutations linked to late-onset Parkinson's (PMID: 22036963)
- Retrograde axonal transport defects precede motor symptoms in PD models (PMID: 24722928)
- Retromer agonism by bicyclic peptide enhances neurotrophin signaling (PMID: 29249286)
**Predicted Experiment:** Time-lapse imaging of TrkB-mScarlet in axons of human neurons; split between somatic and axonal fluorescence intensity as compartmentalization index; test pharmacological retromer enhancement (compound CCN1) for reversal.
**Confidence:** 0.62
---
## Hypothesis 5: Synaptic Tagging by Local Translation as Integrated Compartmentalization Readout
**Title:** Co-translational mRNA localization as a sensor for RNA granule trafficking defects in neurodegeneration
**Mechanism:** Local protein synthesis at synaptic compartments requires intact mRNA granule transport (via ZBP1/KHDRBS1 and TDP-43 in granules). Disruption of this process can be measured by imaging β-actin and CaMKIIα mRNA in proximal neurites, and by sampling nascent synaptic proteome using FUNCAT (fluorescent noncanonical amino acid tagging).
**Target Gene/Protein/Pathway:**
- ZBP1 (IGF2BP1) - beta-actin mRNA binding
- TDP-43 in RNA granules